Dina Brauneis

Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study

Vaishali Sanchorawala, Shayna Sarosiek, Amanda Schulman et al. · Blood · 2020 · 152 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +9

Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial

Vaishali Sanchorawala, Dina Brauneis, Anthony C Shelton et al. · Biology of Blood and Marrow Transplantation · 2015 · 63 citations · Full text

Medicine, Hematology, Oncology +15

High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease

Felipe Batalini, Laura Econimo, Karen Quillen et al. · Biology of Blood and Marrow Transplantation · 2017 · 40 citations · Full text

Medicine, Hematology, Nephrology +15

Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis

Raphaël Szalat, Shayna Sarosiek, Andrea Havasi et al. · Leukemia · 2020 · 30 citations

Medicine, Hematology, Surgery +12

Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis

Shayna Sarosiek, Luke Zheng, J. Mark Sloan et al. · Blood Cancer Journal · 2020 · 25 citations · Full text

Medicine, Hematology, Oncology +14